The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action.

Gough SC, Simmonds MJ. · 2007

Read The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. by Gough SC, Simmonds MJ. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2647156.txt.

Introduction

Gough and Simmonds reviewed in 2007 the HLA region, a stretch of DNA packed with immune system genes, and its links to autoimmune disease. In these diseases the body attacks its own tissues. Ties between this region and illnesses such as rheumatoid arthritis, type 1 diabetes, and Graves' disease had been known for over fifty years.

The strongest ties sit in one gene cluster whose products show foreign material to helper T cells, a step that can start an autoimmune attack. Newer studies, using big patient datasets and better statistics, found further ties in nearby parts of the region. These act on their own, apart from the main cluster. One gene, HLA-B, linked strongly to type 1 diabetes, and another, HLA-C, to multiple sclerosis and Graves' disease. The pattern hints that infections and killer T cells help trigger these illnesses.

Catalog record

CREATORGough SC, Simmonds MJ.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2647156

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action By S.C.L Gough, M.J Simmonds Published in: Current Genomics DOI: 10.2174/138920207783591690 ABSTRACT The HLA region encodes several molecules that play key roles in the immune system. Strong association between the HLA region and autoimmune disease (AID) has been established for over fifty years. Association of components of the HLA class II encoded HLA-DRB1-DQA1-DQB1 haplotype has been detected with several AIDs, including rheumatoid arthritis, type 1 diabetes and Graves’ disease. Molecules encoded by this region play a key role in exogenous antigen presentation to CD4+ Th cells, indicating the importance of this pathway in AID initiation and progression. Although other components of the HLA class I and III regions have also been investigated for association with AID, apart from the association of HLA-B*27 with ankylosing spondylitis, it has been difficult to determine additional susceptibility loci independent of the strong linkage disequilibrium (LD) with the HLA class II genes. Recent advances in the statistical analysis of LD and the recruitment of large AID datasets have allowed investigation of the HLA class I and III regions to be re-visited. Association of the HLA class I region, independent of known HLA class II effects, has now been detected for several AIDs, including strong association of HLA-B with type 1 diabetes and HLA-C with multiple sclerosis and Graves’ disease. These results provide further evidence of a possible role for bacterial or viral infection and CD8+ T cells in AID onset. The advances being made in determining the primary associations within the HLA region and AIDs will not only increase our understanding of the mechanisms behind disease pathogenesis but may also aid in the development of novel therapeutic targets in the future. INTRODUCTION Autoimmune diseases (AIDs) including type 1 diabetes (T1D), multiple sclerosis (MS), rheumatoid arthritis (RA), Graves’ disease (GD), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE) affect over 4% of the western population and involve the generation of autoantibodies against self antigen/s. In many cases lymphocytic infiltration of a target organ/s and autoimmune destruction is also observed. These diseases are often chronic and debilitating and, although treatments are available, many are inadequate [1] providing the impetus for a greater understanding of the disease mechanisms and the development of novel therapeutic agents. Antigen presentation and T cell activation appear to be key to triggering an autoimmune response [2] prompting investigation of many genes within this pathway for association with AID including several within the major histocompatibility complex (MHC). The MHC, also known in humans as the human leukocyte antigen (HLA) region, encompasses 7.6Mb on chromosome 6p21 and is the most gene dense region within the human genome encoding 252 expressed loci [3] including several key immune response genes. The region can be subdivided into the extended class I, classical class I, classical class III, classical class II and extended class II regions (Fig. 1) and contains the largest degree of polymorphism within the genome [4]. It also exhibits the most dense linkage disequilibrium (LD) [5], extending up to 540kb, which compares with distances of between 1-173kb seen in the rest of the genome [6, 7]. The extent of LD within the region has proved challenging when trying to tease out the exact location of etiological variants. Most studies have focussed on the role of HLA class II encoded HLA-DR and –DQ molecules, which present exogenous antigens for recognition by CD4+ T helper (Th) cells. Strong associations with almost all AIDs have been detected (see Table 1). ASSOCIATION OF THE HLA CLASS II REGION WITH AID Early experiments investigating association of HLA-DR and -DQ with AID in T1D indicated a strong association of the DRB1*03 and DRB1*04 alleles [8-10]. A stronger association with the DQB1 locus alone was reported when an allele encoding aspartic acid (Asp) at position β57 of DQB1 was found to be associated with resistance to T1D, while an allele encoding a neutral residue, such as alanine (Ala) or serine (Ser) at position β57 conferred susceptibility [11-13]. This molecule forms a critical residue in peptide binding pocket nine (P9) of the DQB1 binding pocket involved in antigen presentation and T cell receptor (TCR) interaction. It’s carboxylate group forms a salt bridge with arginine (Arg) at position α57 of the DQA1 chain that stabilizes the heterodimer between the DQA1 and DQB1 chains [13]. The presence of Asp at this position could alter the stability of the molecule and/or antigen presenting repertoire, thus making the molecule more prone to binding autoreactive antigens. Although this may provide an interesting mechanism for association of the HLA class II region with T1D, further studies have demonstrated a potential role for other residues in DQB1 binding pocket P9 and DRB1 binding pockets P1 and P4 in disease susceptibility [13]. Association with RA is only seen at DRB1, with other associations with DQB1 [14] almost certainly the result of LD with DRB1 [15, 16]. Originally association was attributed to DRB1*04 [17] but other associations have subsequently been reported. Work by Gregerson, et al, showed that association of DRB1 alleles (DRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001 and DRB1*1402) [18, 19] was due to similarities within the DRB1 peptide domain at positions β70 through to β74, with these alleles containing similar sequences (QKRAA/QRRAA/RRRAA) termed the ‘shared epitope’ [18]. Amino acid changes within the shared epitope have been postulated to differentiate the predisposing alleles from the protective DRB1*0103, DRB1*07, DRB1*1201, DRB1*1301 and DRB1*1501 alleles [2, 15, 20]. Recent work on the shared epitope has suggested a new model, whereby the shared epitope only consists of positions β72-β74, and rather than being essential for disease susceptibility, positions β70 and β71 have been proposed to modulate association [21, 22]. Further verification of this hypothesis, re-defining the shared epitope, is required. Association of DRB1 position β74 of the share epitope is not unique to RA. In GD, comparison of the predisposing DRB1*03 and protective DRB1*07 molecules showed DRB1*03 containing a positively charged Arg at β74 and DRB1*07 containing a non-charged polar glutamine (Gln) at this position. Position β74 has also been shown to differentiate between the lower risk DRB1*0403 and *0406 T1D alleles, which contain a negatively charged glutamic acid (Glu), compared to the high risk DRB1*0401 allele which contain a non-charged polar Ala [23-26]. Interestingly the DRB1*07 haplotype is also protective against T1D and RA [27-29]. Amino acid (74 spans several binding environments involved in autoantigen binding/presentation and T cell antigen receptor docking and interaction [30], suggesting that changes within peptide and TCR binding could determine which amino acids are presented to the immune system. Further work on DRB1 and DQB1 showed that there was LD between these molecules and, along with DQA1, they were found to form part of extended haplotypes DRB1*03-DQB1*02-DQA1*0501 (DR3) and DRB1*04-DQB1*0302-DQA1*0301 (DR4) associated with T1D [2, 31]. Overlap between HLA class II associations has been seen between AIDs, with DR3 also being associated with GD, SLE and HT, therefore, being termed the ‘autoimmunity haplotype’ (See Table 1 for list of common AID HLA class II associations). DR4 is also associated with other AIDs, including HT. Statistical modelling techniques, including logistic regression analysis, have been employed to determine which components of the DRB1-DQB1-DQA1 haplotype contain the etiological variants associated

Read the complete text